Lifeline

The Lancet Neurology · Published 2026-06-17 · DOI 10.1016/s1474-4422(26)00210-3

Authors being retrieved — see the publisher record. https://doi.org/10.1016/s1474-4422(26)00210-3

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

The epidemiology of unruptured intracranial aneurysm in Finland – Authors’ reply · The Lancet Neurology · 2026 · Same journal
Virus-specific T-cell therapy for neuroinvasive West Nile virus · The Lancet Neurology · 2026 · Same journal
Optic nerve involvement in multiple sclerosis diagnosis – Authors’ reply · The Lancet Neurology · 2026 · Same journal
Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trial · The Lancet Neurology · 2026 · Same journal
Natural experiments on herpes zoster vaccines and dementia · The Lancet Neurology · 2026 · Same journal
Diagnosis of exclusion versus no better explanation · The Lancet Neurology · 2026 · Same journal
Uwe Reuter: a leader in migraine · The Lancet Neurology · 2026 · Same journal
Building systems-based epilepsy surgery in sub-Saharan Africa · The Lancet Neurology · 2026 · Same journal
UCL Queen Square Institute of Neurology: 75 years of innovation · The Lancet Neurology · 2026 · Same journal
Safety and efficacy of staged, bilateral magnetic resonance-guided focused ultrasound pallidothalamic tractotomy for motor complications of Parkinson's disease: a prospective, multicentre, single-arm trial · The Lancet Neurology · 2026 · Same journal